Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Hoffmann-La Roche
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Jazz Pharmaceuticals
DualityBio Inc.
Daiichi Sankyo
Mayo Clinic
I-Mab Biopharma US Limited
Sotio Biotech Inc.
National Institutes of Health Clinical Center (CC)
Pfizer
University of California, Irvine
Elevation Oncology
Exelixis
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
pharmaand GmbH
Canadian Cancer Trials Group
Hoffmann-La Roche
OncoNano Medicine, Inc.
Northwestern University
Istituto Clinico Humanitas
Duke University
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Seagen Inc.
Cambridge University Hospitals NHS Foundation Trust
Eli Lilly and Company
Novartis
Washington University School of Medicine
Novartis
Dana-Farber Cancer Institute
Schillerhoehe Hospital
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
Scripps Health